Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility

Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility

Inhibikase Therapeutics announced the sale of 25 million shares through its at-the-market facility, raising $50 million gross. The capital is intended to support operations through topline data readout of Part B of its global Phase 3 IMPROVE-PAH trial evaluating IKT-001 for Pulmonary Arterial Hypertension. The transaction involved RA Capital Manage…

Sunrun’s California Distributed Power Plant Expands Dispatch Capacity to 425 Megawatts to Provide Statewide Grid Relief

Sunrun’s California Distributed Power Plant Expands Dispatch Capacity to 425 Megawatts to Provide Statewide Grid Relief

Sunrun Inc., a U.S. leader in home battery storage and solar energy, announced the expansion of its California distributed power plant to provide up to 425 megawatts of dispatchable capacity. This growth is supported by over 80,000 enrolled households, a fivefold increase from 2024, and participation in key state grid service programs. The expansio…

CBAK Energy Reports Progress in Customer Testing of Full-Tab 26650 LFP Cells for AI Data Center Backup Power

CBAK Energy Reports Progress in Customer Testing of Full-Tab 26650 LFP Cells for AI Data Center Backup Power

CBAK Energy Technology Limited has made substantial progress in developing full-tab 26650 cylindrical LFP cells designed specifically for AI data center backup power applications such as BBUs and UPSs. After a 15-month R&D program, the company’s new battery cells demonstrate superior high-rate discharge performance, thermal management, and lifecycl…

Linkhome Holdings Launches OpenLink AI Compute Platform and Executes Definitive US$10.5 Million Enterprise AI Compute Services Agreement

Linkhome Holdings Launches OpenLink AI Compute Platform and Executes Definitive US$10.5 Million Enterprise AI Compute Services Agreement

Linkhome Holdings Inc., a NASDAQ-listed AI real estate and fintech company, announced the commercial launch of its decentralized AI compute platform, OpenLink, and secured a definitive two-year enterprise agreement valued up to $10.5 million. OpenLink provides a decentralized marketplace connecting distributed GPU infrastructure providers with ente…

Globavend Reports First Half Fiscal 2026 Results, Highlights Continued Logistics Growth and Strong Financial Position

Globavend Reports First Half Fiscal 2026 Results, Highlights Continued Logistics Growth and Strong Financial Position

Globavend Holdings Limited (NASDAQ: GVH) announced its unaudited financial results for the six months ended March 31, 2026, highlighting an 8.0% increase in revenue driven by higher shipment volumes in its cross-border logistics and air freight forwarding businesses. Despite operating challenges such as higher freight costs and increased expenses, …

Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor

Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor

Immutep Limited announced the grant of its fourth U.S. patent covering the use of eftilagimod alfa in combination with PD-1 or PD-L1 inhibitors for cancer treatment. The new patent, expiring in 2036, strengthens Immutep's intellectual property portfolio around its lead immunotherapy candidate, supporting ongoing development and business expansion o…

Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access

Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access

Humacyte, Inc. has announced the appointments of Dr. Robert J. Kossmann and Dr. Prabir Roy-Chaudhury as advisors to support the planned commercialization of its acellular tissue engineered vessel (ATEV) product for hemodialysis access. These appointments come after positive Phase 3 clinical trial results and plans to file a supplemental Biologic Li…

AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding

AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding

AEON Biopharma announced a priced public offering of approximately $13.75 million through the issuance of common stock and pre-funded warrants, accompanied by milestone warrants that could provide an additional $29.6 million in future funding. The capital will be used to support ABP-450, their biosimilar to BOTOX for therapeutic use, focusing on an…

VisionWave Files U.S. Provisional Patent Application for SkyWeave™, an AI-Orchestrated Satellite-Free Global Communication Ecosystem

VisionWave Files U.S. Provisional Patent Application for SkyWeave™, an AI-Orchestrated Satellite-Free Global Communication Ecosystem

VisionWave Holdings filed a U.S. provisional patent application for SkyWeave™, an AI-orchestrated high-frequency communication ecosystem designed to enable resilient, long-range communication in environments where satellite and traditional infrastructure are unavailable or compromised. This technology targets defense, autonomous systems, emergency …

Landstar to Release Second Quarter Results on Tuesday, July 28, 2026

Landstar to Release Second Quarter Results on Tuesday, July 28, 2026

Landstar System, Inc., a technology-enabled transportation management solutions provider, announced it will release its second quarter 2026 financial results on July 28 after market close, followed by a conference call for analysts and investors. The company highlighted its network-based asset-light business model and commitment to ISO quality and …

Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

Hemab Therapeutics announced at ISTH 2026 sustained bleed reduction and manageable safety from Phase 2 long-term extension data of sutacimig, a bispecific antibody candidate for Glanzmann thrombasthenia (GT). The company received FDA alignment to initiate Phase 3 trials in the second half of 2026. Preclinical data in Factor VII deficiency (FVIID) s…

ZenaTech Signs Multiple Offers to Acquire Land Surveying and Geospatial Services Companies Across the U.S., Canada and Australia, Expected to Contribute C$40 Million in Revenue During the First 12 Months Following Closing

ZenaTech Signs Multiple Offers to Acquire Land Surveying and Geospatial Services Companies Across the U.S., Canada and Australia, Expected to Contribute C$40 Million in Revenue During the First 12 Months Following Closing

ZenaTech, Inc. announced it has signed offers to acquire multiple land surveying and geospatial service companies across the US, Canada, and Australia. These acquisitions are expected to generate approximately C$40 million in revenue within the first 12 months after closing. This move advances ZenaTech's strategy to build a leading Drone as a Servi…

Bread Financial Announces Executive Leadership Changes

Bread Financial Announces Executive Leadership Changes

Bread Financial announced leadership changes in its commercial organization with Valerie Greer, EVP and Chief Commercial Officer, retiring after nearly 40 years in financial services. Dennis McCarthy will be promoted to EVP and Chief Revenue Officer, bringing extensive industry experience to guide the company’s next growth phase. Greer will remain …

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

CervoMed Inc. announced new clinical, biomarker, and imaging data for its investigational drug neflamapimod in treating Dementia with Lewy Bodies (DLB) presented at AAIC 2026. Results from the Phase 2b trial and additional studies reinforce neflamapimod’s potential to slow disease progression, particularly in DLB patients without Alzheimer’s co-pat…